Efavirenz in the therapy of HIV infection

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

(2009) Richard H Haubrich et al.   AIDS

Influence of the Cytochrome P450 2B6 Genotype on Population Pharmacokinetics of Efavirenz in Human Immunodeficiency Virus Patients

(2009) S. E. Cabrera et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

CYP2B6(c.516G→T) andCYP2A6(*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients

(2009) Awewura Kwara et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Efavirenz Treatment and False‐Positive Results in Benzodiazepine Screening Tests

(2009) Antje Blank et al.   CLINICAL INFECTIOUS DISEASES

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals

(2009) M Arab-Alameddine et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Efavirenz in Human Breast Milk, Mothersʼ, and Newbornsʼ Plasma

(2009) Serge Schneider et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

CYP2B6Variants and Plasma Efavirenz Concentrations during Antiretroviral Therapy in Port‐au‐Prince, Haiti

(2009) Paul Leger et al.   JOURNAL OF INFECTIOUS DISEASES

In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function

(2009) Julia di Iulio et al.   Pharmacogenetics and Genomics

Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers

(2008) Bharat Damle et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel

(2008) Martin S. Hirsch et al.   CLINICAL INFECTIOUS DISEASES

Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives

(2008) Shareen Y. El-Ibiary et al.   EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE

Slow Efavirenz Metabolism Genotype Is Common in Botswana

(2008) Robert Gross et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

(2008) C. Wyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

(2008) Sharon A. Riddler et al.   NEW ENGLAND JOURNAL OF MEDICINE

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

(2003) Susan M. Clarke et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY